Hollings Headlines // August 2020
Welcoming our new director
Dr. Raymond DuBois, M.D., Ph.D., joins MUSC Hollings Cancer Center this month as its new director. Here’s the announcement in case you missed it and a Q&A that appeared in The Cancer Letter.
Norman E. “Ned” Sharpless, M.D., Director, National Cancer Institute, praised the choice of Dr. DuBois for this role:
“I have worked with him closely during his service as chair of the NCI Board of Scientific Counselors and as a member of the Frederick National Laboratory Advisory Committee. He recognizes and promotes research excellence, has a proven track record, and strongly supports patient-centered cancer care. He will certainly elevate Hollings Cancer Center as well as the whole cancer effort in the State of South Carolina.”
We want to thank all our care team members and staff for their hard work. Their dedication and passion shows up in the great rankings that we get, such as the latest U.S. News & World Report rankings that place cancer care at MUSC Health among the top 40 ranked programs nationally.

Says Dr. David Mahvi, M.D., chief of the Oncology Integrated Center of Clinical Excellence:
“I'm thankful for the amazing oncology care team members we have who provide such compassionate and quality care, a key component of what makes our program so strong in national rankings. Our team never took a break during the pandemic. Their dedication to providing outstanding care is humbling.”
Help us fill up the map! This year our event has gone virtual, so we’re extending our reach. We hope to get participants from all 50 states, so please register and invite friends and family who live across the nation to join you. There are so many reasons to participate, but here are our top three:

1.     It raises money for lifesaving cancer research.
2.     It’s free unless you get the cute T-shirt, and then it’s still only $25.
3.     It inspires you to be active and raises cancer awareness.

Want to learn more? Check out this story about our virtual event and visit the LOWVELO website to register.
When Lucy Boyce, our farthest away participant, isn’t logging miles for LOWVELO or working remotely for Hollings Tumor Registry, she can be found halibut fishing, hiking and navigating life in the wilds of Alaska. Her interview for this story about her got interrupted so she could chase a bear out of her cherry tree.
Join us for the first LOWVELO social hour!

MUSC is at the forefront of the COVID crisis, and many MUSC Hollings Cancer Center researchers are leading the charge in discovery and innovation. Hear the latest information on COVID-19 research and patient care from our researchers and oncologists. This virtual event is open to the public.

COVID and Cancer
Thursday, August 20
5 p.m. - 6 p.m.
Patient Spotlight
Faith over fear

Five-time cancer survivor Donna Rosa never gave up and wants to help others as she treasures time with her family and raises awareness about melanoma.

Coping with COVID-19
Fighting back against quarantine fatigue

Feeling more tired or irritable lately? You’re not alone and one of our therapists explains how to best cope with quarantine fatigue.

Protecting cancer patients during the pandemic

Tune in to hear Dr. David Mahvi, M.D., who is featured in this NPR Health Focus interview, talk about health concerns cancer patients face during the pandemic and how the cancer center is addressing it. Dr. Mahvi is our chief of the Oncology Integrated Center of Clinical Excellence.

New database could help lead to personalized treatments for breast cancer patients

“Cell lines are the front line for breast cancer research because they are derived from real patients and exhibit the characteristics of the disease that that patient experienced,” explains MUSC Hollings Cancer Center researcher Stephen P. Ethier, Ph.D., in this story that explores a new database of 40 breast cancer cell lines that is available to help researchers find cures.
A different approach drives success: Hollings Cancer Center researcher receives two NIH R01 grants

Jessica Thaxton, Ph.D., received two NCI grants totaling $3.4 million for her work in cancer immunotherapy and cell stress, one of which is part of the Cancer Moonshot Initiative on immunometabolism.
Save the Dates
Virtual NCI event - New Era in Cancer Research and Discovery

Cancer Research UK and the National Cancer Institute, the largest funders of cancer research in the world, are uniting to define a new era in cancer research. They are hosting a virtual event to mark this monumental new partnership for Cancer Grand Challenges and gain insight into our joint ambition to take on the greatest problems standing in the way of progress against cancer.

Thursday, August 27
10:30 a.m.

Drug Discovery Core Lunch and Learn

The MUSC Drug Discovery Core (DDC) is a specialized resource providing tools, facilities, and expertise for therapeutic development, chemical biology, and translational science.

Wednesday, September 9
12 p.m. - 1 p.m.

2020 AACI/CCAF Virtual Annual Meeting
This year’s meeting will begin at 8:30 a.m. on Monday, October 12, and end at 4 p.m. on Tuesday, October 13. Registration for the virtual meeting is free for AACI cancer center members and sustaining members. Learn more about the program and register online

October 12 - 13
8:30 a.m. - 4 p.m.
Key Links Reference Section
86 Jonathan Lucas Street, Charleston, SC 29425 | Privacy Policy
Connect With Us